| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.02 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.02 |